Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Axonics, Inc. (AXNX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 7,675 shares
@ $56.8717, valued at
$436.5k
Exercised 11,250 options to buy
@ $0 |
|
| 08/17/2023 |
4
| Ford Alfred J Jr (Chief Commercial Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 14,769 shares
@ $62.3381, valued at
$920.7k
|
|
| 08/08/2023 |
4
| CARREL MICHAEL H (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Gifted 500 shares
@ $0 |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Demski David M (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| Lopez Esteban (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| CARREL MICHAEL H (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 06/28/2023 |
4
| McNamara Robert (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 05/31/2023 |
4
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 7,699 shares
@ $49.4355, valued at
$380.6k
Sold 300 shares
@ $50.14, valued at
$15k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Dearen Danny L. (President & CFO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 7,198 shares
@ $54.8346, valued at
$394.7k
Sold 7,802 shares
@ $55.6785, valued at
$434.4k
Exercised 6,633 options to buy
@ $14.19, valued at
$94.1k
Exercised 5,468 options to buy
@ $25.82, valued at
$141.2k
Exercised 2,899 options to buy
@ $1.63, valued at
$4.7k
|
|
| 02/23/2023 |
4
| Sama Rinda (COO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 16,229 shares
@ $56.176, valued at
$911.7k
Sold 3,700 shares
@ $56.685, valued at
$209.7k
Sold 3,392 shares
@ $56.53, valued at
$191.7k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Woock John (EVP, Chief Mktg/Strtgy Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 2,793 shares
@ $67.6174, valued at
$188.9k
Sold 378 shares
@ $67.5113, valued at
$25.5k
Sold 15,000 shares
@ $67.2923, valued at
$1M
Sold 12,044 shares
@ $67.3175, valued at
$810.8k
Exercised 12,044 options to buy
@ $25.82, valued at
$311k
Exercised 15,000 options to buy
@ $14.19, valued at
$212.9k
Exercised 378 options to buy
@ $1.42, valued at
$536.8
Exercised 2,793 options to buy
@ $1.32, valued at
$3.7k
|
|
| 01/18/2023 |
4
| COHEN RAYMOND W (CEO) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 18,684 shares
@ $65.5409, valued at
$1.2M
Sold 22,052 shares
@ $66.2722, valued at
$1.5M
|
|
| 01/18/2023 |
4
| Ford Alfred J Jr (Chief Commercial Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 15,292 shares
@ $65.8972, valued at
$1M
Sold 17,108 shares
@ $66.6866, valued at
$1.1M
Sold 3,615 shares
@ $67.1759, valued at
$242.8k
Exercised 9,310 options to buy
@ $25.82, valued at
$240.4k
Exercised 16,297 options to buy
@ $14.19, valued at
$231.3k
Exercised 1,899 options to buy
@ $1.63, valued at
$3.1k
Exercised 8,509 options to buy
@ $1.42, valued at
$12.1k
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| Noblett Karen (Chief Medical Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 32,483 shares
@ $78.1578, valued at
$2.5M
Exercised 18,519 options to buy
@ $14.19, valued at
$262.8k
Exercised 13,964 options to buy
@ $25.82, valued at
$360.6k
|
|
| 09/15/2022 |
4
| Dearen Danny L. (See Remarks) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 656 shares
@ $75.6, valued at
$49.6k
|
|
| 09/12/2022 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 3,800 shares
@ $75.0063, valued at
$285k
Sold 3,700 shares
@ $75, valued at
$277.5k
Exercised 3,700 options to buy
@ $1.63, valued at
$6k
Exercised 3,800 options to buy
@ $1.42, valued at
$5.4k
|
|
| 09/09/2022 |
4
| Noblett Karen (Chief Medical Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 10,454 shares
@ $71.5319, valued at
$747.8k
|
|
| 08/26/2022 |
4
| Woock John (Chief Marketing Officer) has filed a Form 4 on Axonics, Inc.|
Txns:
| Sold 6,958 shares
@ $72.9181, valued at
$507.4k
Sold 542 shares
@ $73.3369, valued at
$39.7k
|
|
| 08/22/2022 |
4
| Lopez Esteban (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,100 shares
@ $0 |
|
| 08/22/2022 |
4
| Demski David M (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,100 shares
@ $0 |
|
| 08/22/2022 |
4
| Kiernan Jane E (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,100 shares
@ $0 |
|
| 08/22/2022 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,100 shares
@ $0 |
|
|
|
|